NFG
ABBV icon

Nations Financial Group’s AbbVie ABBV Stock Holding History

Nations Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.37M Sell
21,335
-144
-0.7% -$31K 0.26% 90
2026
Q1 		$4.67M Buy
21,479
+103
+0.5% +$22.8K 0.24% 100
2025
Q4 		$4.88M Buy
21,376
+4,956
+30% +$1.13M 0.26% 95
2025
Q3 		$3.8M Buy
16,420
+14
+0.1% +$2.85K 0.24% 101
2025
Q2 		$3.05M Buy
16,406
+134
+0.8% +$24.9K 0.21% 120
2025
Q1 		$3.41M Buy
16,272
+2,269
+16% +$441K 0.26% 95
2024
Q4 		$2.49M Sell
14,003
-13,955
-50% -$2.57M 0.18% 141
2024
Q3 		$5.52M Buy
27,958
+4,566
+20% +$852K 0.4% 54
2024
Q2 		$4.01M Buy
23,392
+8,942
+62% +$1.48M 0.33% 67
2024
Q1 		$2.63M Sell
14,450
-1,380
-9% -$238K 0.22% 112
2023
Q4 		$2.45M Sell
15,830
-157
-1% -$22.9K 0.23% 109
2023
Q3 		$2.38M Sell
15,987
-206
-1% -$30.2K 0.24% 105
2023
Q2 		$2.18M Sell
16,193
-449
-3% -$65.8K 0.21% 113
2023
Q1 		$2.65M Sell
16,642
-107
-0.6% -$16.4K 0.28% 91
2022
Q4 		$2.71M Buy
16,749
+1,597
+11% +$245K 0.3% 81
2022
Q3 		$2.03M Sell
15,152
-12,424
-45% -$1.78M 0.29% 80
2022
Q2 		$4.22M Sell
27,576
-6,327
-19% -$967K 0.57% 33
2022
Q1 		$5.5M Buy
33,903
+1,244
+4% +$181K 0.66% 29
2021
Q4 		$4.42M Buy
32,659
+19,021
+139% +$2.25M 0.58% 32
2021
Q3 		$1.47M Buy
13,638
+3,825
+39% +$437K 0.22% 113
2021
Q2 		$1.1M Buy
9,813
+86
+0.9% +$9.69K 0.19% 149
2021
Q1 		$1.05M Sell
9,727
-3,214
-25% -$344K 0.24% 117
2020
Q4 		$1.39M Buy
12,941
+1,148
+10% +$110K 0.37% 72
2020
Q3 		$1.03M Buy
11,793
+529
+5% +$49.8K 0.32% 87
2020
Q2 		$1.11M Buy
11,264
+1,149
+11% +$101K 0.39% 68
2020
Q1 		$771K Buy
10,115
+600
+6% +$51.1K 0.33% 89
2019
Q4 		$843K Buy
9,515
+3,050
+47% +$253K 0.29% 109
2019
Q3 		$514K Buy
6,465
+1,761
+37% +$121K 0.18% 164
2019
Q2 		$342K Buy
4,704
+863
+22% +$67.8K 0.23% 119
2019
Q1 		$310K Buy
3,841
+252
+7% +$20.6K 0.21% 123
2018
Q4 		$331K Sell
3,589
-69
-2% -$6.07K 0.27% 106
2018
Q3 		$346K Buy
3,658
+226
+7% +$21.4K 0.25% 111
2018
Q2 		$318K Buy
3,432
+202
+6% +$19.7K 0.27% 111
2018
Q1 		$306K Buy
3,230
+151
+5% +$16.6K 0.28% 104
2017
Q4 		$298K Buy
3,079
+85
+3% +$8.01K 0.27% 114
2017
Q3 		$266K Buy
2,994
+1
+0% +$76 0.26% 118
2017
Q2 		$217K Buy
+2,993
New +$201K 0.18% 157

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Nations Financial Group's ABBV Position: Q2 2026 in Review

Nations Financial Group reduced its AbbVie (ABBV) stake by 0.67% in Q2 2026, selling an estimated $31K and leaving 21,335 shares worth $5.37M. The position accounts for 0.26% of the portfolio, ranked #90.

Nations Financial Group first reported a position in ABBV in Q2 2017 and has held it in 37 quarters since. The position peaked at $5.52M in Q3 2024. 1,328 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Nations Financial Group held 21,335 shares of AbbVie worth $5.37M as of Q2 2026.
  • Nations Financial Group sold 144 AbbVie shares in Q2 2026, an estimated $31K.
  • AbbVie made up 0.26% of Nations Financial Group's portfolio in Q2 2026, its #90 holding.
  • Nations Financial Group first reported a position in AbbVie in Q2 2017 and has held it in 37 quarters since.
  • Nations Financial Group's AbbVie position peaked at $5.52M in Q3 2024.
  • 1,328 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.